Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. has successfully completed a subscription, issuing 4,423,870 new domestic shares, bringing its total to 227,267,969 shares. This move alters the company’s shareholding structure and required amendments to its Articles of Association, reflecting changes in registered capital. Investors may find this expansion promising as it aligns with the company’s growth ambitions.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.